Management of Postpartum Hemorrhage and Anemia

Immediate Assessment and Diagnostic Workup

• The American College of Obstetricians and Gynecologists recommends measuring cumulative blood loss accurately using volumetric and gravimetric techniques, as blood loss is frequently underestimated during cesarean section 1
• The American Society of Anesthesiologists suggests calculating the Shock Index (heart rate ÷ systolic blood pressure): A Shock Index >1 categorizes the patient as "unstable" requiring immediate intervention 2
• Obtain urgent laboratory tests, including complete blood count with current hemoglobin, coagulation studies, fibrinogen level, and venous blood gas for rapid hemoglobin measurement and lactate, as recommended by the American Association of Blood Banks 1, 3
• Perform focused physical examination looking for signs of ongoing vaginal bleeding or hematoma formation, vital signs including blood pressure, respiratory rate, oxygen saturation, and signs of hypovolemia, as suggested by the British Journal of Anaesthesia 1, 4

Transfusion Decision Algorithm

• The American College of Obstetricians and Gynecologists indicates that red blood cell transfusion is recommended for hemoglobin <7.0 g/dL, and considers transfusion if the patient has cardiac disease or ongoing bleeding for hemoglobin 7.0-8.0 g/dL 1, 3
• Transfuse one unit at a time and recheck hemoglobin before each subsequent unit, unless there is active bleeding, as recommended by the American Association of Blood Banks 1

Management of Ongoing Hemorrhage

• Assemble a multidisciplinary team immediately if bleeding exceeds 1000 mL after cesarean delivery, as suggested by the American College of Obstetricians and Gynecologists 1, 5
• Administer tranexamic acid 1 g IV if severe hemorrhage is confirmed, ideally within 3 hours of bleeding onset, as recommended by the World Health Organization 1, 5, 2
• Monitor fibrinogen levels and administer cryoprecipitate or fibrinogen concentrate to maintain levels >1.5-2.0 g/L if Clauss fibrinogen is <3 g/L with ongoing bleeding, as suggested by the American Association of Blood Banks 1, 5, 3

Special Considerations for Severe Preeclampsia

• The European Society of Cardiology notes that severe preeclampsia increases the risk of coagulopathy, particularly when associated with HELLP syndrome, and recommends monitoring for progression to HELLP syndrome with liver enzyme testing and platelet count 4, 6
• Continue antihypertensive management with agents like hydralazine infusion to maintain mean arterial pressure <105 mmHg and prevent eclampsia or intracranial hemorrhage, as recommended by the American College of Obstetricians and Gynecologists 4, 6

Critical Pitfalls to Avoid

• Do not rely on visual estimation of blood loss, as it consistently underestimates actual blood loss and delays appropriate intervention, as warned by the American College of Obstetricians and Gynecologists 1, 5, 3
• Do not wait for laboratory results to initiate resuscitation in cases of obvious severe hemorrhage with hemodynamic instability, as emphasized by the American Society of Anesthesiologists 1, 5

Ongoing Monitoring Plan

• Continue vital sign monitoring every 1-2 hours for the first 24 hours postpartum, as recommended by the European Society of Cardiology 6
• Recheck hemoglobin 4-6 hours after initial assessment or sooner if clinical deterioration occurs, as suggested by the American Association of Blood Banks 3
• Monitor urine output, as oliguria may indicate ongoing hypovolemia or progression of preeclampsia, as noted by the British Journal of Anaesthesia 4

Transfusion Indications in Pregnancy with Coagulopathy and Hemorrhage

Primary Transfusion Threshold and Hemorrhage Management

• In obstetric hemorrhage without known coagulation results, withhold fresh frozen plasma (FFP) until four units of red blood cells have been given, unless early coagulopathy is diagnosed on coagulation screening, as recommended by the American Society of Anesthesiologists 7
• After four units of RBCs with ongoing bleeding and no coagulation results available, infuse four units of FFP and maintain 1:1 ratio of RBC:FFP until hemostatic test results are known, according to the American College of Obstetricians and Gynecologists 7
• Prioritize fibrinogen replacement when Clauss fibrinogen is <3 g/L with ongoing bleeding, as this strongly predicts progression to massive obstetric bleeding (>2500 mL), as stated by the International Society on Thrombosis and Haemostasis 7
• Severe hypofibrinogenemia (fibrinogen <2 g/L) occurs in approximately 5% of bleeds at 1000 mL and is associated with placental abruption, amniotic fluid embolus, and severe bleeding with sepsis and pre-eclampsia, according to the American College of Obstetricians and Gynecologists 7

Coagulation Monitoring and Transfusion Thresholds

• Use PT ratio and APTT ratio ≥1.5 as the cutoff for coagulopathy in pregnancy, rather than absolute values in seconds, as recommended by the International Society on Thrombosis and Haemostasis 8, 9
• PT and APTT are physiologically shortened in pregnancy (median PT 9.60 seconds, APTT 31.00 seconds at 36 weeks) due to increased coagulation factors, according to the American College of Obstetricians and Gynecologists 8, 9
• Any prolongation of PT and APTT above normal non-pregnant range may indicate factor depletion and should be managed with FFP, as stated by the American Society of Anesthesiologists 7

Adjunctive Hemostatic Therapy

• Administer tranexamic acid 1 g IV immediately when postpartum hemorrhage is identified (>500 mL vaginal delivery, >1000 mL cesarean delivery), ideally within 3 hours of bleeding onset, as recommended by the World Health Organization 7
• Tranexamic acid reduces total blood loss and should be given if severe hemorrhage is confirmed, according to the American College of Obstetricians and Gynecologists 7

Platelet Transfusion Thresholds

• Transfuse platelets when platelet count is <75 × 10⁹/L in the setting of obstetric hemorrhage, as recommended by the American Society of Anesthesiologists 7
• Platelet transfusion is rarely required unless postpartum hemorrhage exceeds 5000 mL or platelet count was <100 × 10⁹/L from another cause prior to hemorrhage, according to the American College of Obstetricians and Gynecologists 7

PRBC Transfusion in Postpartum Hemorrhage

Clinical Context and Transfusion Triggers

• The American College of Obstetricians and Gynecologists recommends PRBC transfusion in patients with ongoing hemorrhage and lactic acidosis, despite a hemoglobin of 10 g/dL, as the presence of active bleeding and metabolic markers of inadequate tissue perfusion override static hemoglobin thresholds 10, 11
• In active hemorrhage, hemoglobin concentration remains falsely elevated due to inadequate fluid resuscitation and hemoconcentration, indicating the need for transfusion regardless of hemoglobin level 11
• Lactic acidosis indicates inadequate oxygen delivery to tissues, which is a primary indication for RBC transfusion independent of hemoglobin level 11
• The American College of Obstetricians and Gynecologists recommends transfusion in unstable patients with active bleeding when Hct <30% (Hb ~10 g/dL) 10
• The standard restrictive threshold of Hb 7 g/dL applies only to stable patients without active bleeding, normovolemic patients, and patients without signs of inadequate oxygen delivery 11

Transfusion Strategy and Monitoring

• The American College of Obstetricians and Gynecologists recommends transfusing PRBCs based on clinical instability and ongoing hemorrhage, not the hemoglobin value alone 10, 11
• After 4 units of PRBCs with ongoing bleeding, initiate FFP at 1:1 ratio with RBCs, and monitor fibrinogen levels to maintain >2 g/L (ideally >3 g/L with ongoing bleeding) 12
• Hypofibrinogenemia <2 g/L is associated with severe postpartum hemorrhage and develops early when plasma-poor red cells are used for replacement 10, 12

Common Pitfalls to Avoid

• Do not wait for hemoglobin to drop to 7 g/dL in the setting of active hemorrhage, as blood loss is consistently underestimated, and hemoglobin/hematocrit values do not fall for several hours after acute hemorrhage 11, 13
• Do not rely on visual estimation of blood loss, as it consistently underestimates actual blood loss by 30-50% and delays appropriate intervention 13
• Do not delay transfusion waiting for laboratory confirmation when clinical signs indicate hemodynamic instability (tachycardia, hypotension, altered mental status, oliguria) 11, 13

Transfusion Decision‑Making in Stable Postpartum Anemia

Clinical Assessment of Anemia Symptoms

• Evaluate postpartum women for dyspnea, syncope, tachycardia, angina, or neurological manifestations; the presence of any of these symptoms suggests that blood transfusion may be required rather than iron therapy alone. 14

Transfusion Indication Criteria

• In a hemodynamically stable postpartum patient with a hemoglobin level of 7.4 g/dL and no anemia‑related symptoms, routine blood transfusion is not recommended. 14
• The European Society of Intensive Care Medicine advises a restrictive transfusion strategy for non‑massive postpartum hemorrhage, basing the decision on shock indices and symptomatology instead of targeting a liberal hemoglobin threshold (e.g., 9 g/dL). 14
• Blood transfusion should be considered only when hemoglobin falls below 7.0 g/dL or when the patient exhibits symptomatic anemia (dyspnea, syncope, tachycardia, angina, or neurological signs). 14
• For asymptomatic, hemodynamically stable patients, the recommended next step is to initiate intravenous iron therapy rather than transfusion. 14

Management of Significant Blood Loss in Anemic Patients During Cesarean Section

Definition & Clinical Significance

Immediate Assessment & Team Coordination

Monitoring Parameters

Transfusion Decision‑Making

Coagulation Assessment

Antifibrinolytic Therapy (Tranexamic Acid)

Special Considerations for Pre‑Existing Anemia

Strength of evidence for the above recommendations was not explicitly stated in the cited sources.